Mercks spending big to support Gardasil, and the HPV vaccine keeps pumping along

Merck & Co.ís immuno-oncology superstar Keytruda has been dominating headlines and sales rankings for the pharma giant, but it has another growth engine making waves around the world, too. HPV vaccine Gardasil 9 has been pumping in recent years, and the trend continued in the second quarter. The shot posted 50% growth at constant exchange rates over last years second quarter to $886 million. And the company is gearing up to keep the shots growth coming.

Upload Company Info



Chemxpert Demo Video


Dataset Sample


Chemical Name

Synonyms

Molecular Formula

Molecular Weight


To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Innovator

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Market Status

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Indication

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Dataset Sample


Product Name Therapeutic Segment

To Access this information please pay by using "Pay & Download" button.

Pay & Download

To Access this information please pay by using "Pay & Download" button.

Pay & Download

Thank you for your enquiry

Your product will be updated soon in our database


Submit Your Query



Select Any Option



Page loaded in 0.001187 seconds